The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
J | Antiinfectives for systemic use | |
2
|
J04 | Antimycobacterials | |
3
|
J04A | Drugs for treatment of tuberculosis | |
4
|
J04AK | Other drugs for treatment of tuberculosis | |
5
|
J04AK06 |
| Active Ingredient |
|---|
|
The pharmacological mode of action of delamanid involves inhibition of the synthesis of the mycobacterial cell wall components, methoxy-mycolic and keto-mycolic acid. The identified metabolites of delamanid do not show anti-mycobacterial activity. |
| Document | Type | Information Source | |
|---|---|---|---|
| DELTYBA Dispersible tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| DELTYBA Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.